Duyurular
Ä°ÅŸ BaÅŸvurusu
Ä°ÅŸ BaÅŸvurusu
Duyurular
Duyurular
KVKK
KVKK
Optimaven 50g / 240mL Oral Suspension
Activated Carbon + Sorbitol 70/70 (L inactive)
Optimaven 50g / 240mL Oral Suspension
Activated Carbon + Sorbitol 70/70 (L inactive)
![](https://static.wixstatic.com/media/035244_d689ceddf4ed40e1b2122bab3a5e38fc~mv2.png/v1/fill/w_18,h_18,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/035244_d689ceddf4ed40e1b2122bab3a5e38fc~mv2.png)
![](https://static.wixstatic.com/media/035244_d8e2397534c24db1a7e7a10991d73ccc~mv2.png/v1/fill/w_18,h_18,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/035244_d8e2397534c24db1a7e7a10991d73ccc~mv2.png)
![](https://static.wixstatic.com/media/035244_d689ceddf4ed40e1b2122bab3a5e38fc~mv2.png/v1/fill/w_18,h_18,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/035244_d689ceddf4ed40e1b2122bab3a5e38fc~mv2.png)
![](https://static.wixstatic.com/media/035244_e6828d11d0ef465a8c1b263e4c31d602~mv2.png/v1/fill/w_18,h_18,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/035244_e6828d11d0ef465a8c1b263e4c31d602~mv2.png)
![](https://static.wixstatic.com/media/035244_6d553d072d074906921789d726bc57ca~mv2.png/v1/fill/w_18,h_18,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/035244_6d553d072d074906921789d726bc57ca~mv2.png)
![](https://static.wixstatic.com/media/035244_e6828d11d0ef465a8c1b263e4c31d602~mv2.png/v1/fill/w_18,h_18,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/035244_e6828d11d0ef465a8c1b263e4c31d602~mv2.png)
+90 242 344 31 33
HOME / PHARMACOVIGILANCE UNIT
Pharmacovigilance
Post-Market Inspection[PMS]
![pharmacovigilance-2.png](https://static.wixstatic.com/media/84a948_3287fbebf5f840dab59dae5a17da4b6d~mv2.png/v1/fill/w_240,h_116,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/pharmacovigilance-2.png)
Notifications received by Healthcare Professionals, patients or our employees and qualified as Adverse Effects by the Pharmacovigilance Officer; It is recorded in the Individual Case Safety Report Form. Adverse Effect notifications can also be reached by Health Professionals via the Adverse Effect Report Form published by TÜFAM.
In addition, all Customer Complaints that reach our company are also against the possibility of any adverse effects; The Customer Complaint Result Forms prepared in accordance with the Customer Complaint Management Instruction are submitted to the Pharmacovigilance Officer for review.
When it is decided that the complaint received as a result of this examination by the Pharmacovigilance Officer is Adverse Effect, the procedures; It is done in accordance with the relevant regulation, guideline and pharmacovigilance procedure.
In cases evaluated as complaints by the Pharmacovigilance Officer; transactions are continued according to the Customer Complaints Management Instruction.